Selpercatinib-induced Redifferentiation and Enhanced Radioiodine Uptake in Radioiodine-refractory Thyroid Cancer: A Case Report. Zhang Z, Zhou J, Liu Y, Zhang Y, et al. Clin Nucl Med 2026;51:659-660.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang Z, Zhou J, Liu Y, Zhang Y, et al. Selpercatinib-induced Redifferentiation and Enhanced Radioiodine Uptake in Radioiodine-refractory Thyroid Cancer: A Case Report. Clin Nucl Med 2026;51:659-660.
PMID: 42410754